Eye Diseases
Showing 26 - 50 of 140
Age-related Macular Degeneration, Macular Degeneration, Wet Macular Degeneration Trial in Germany, Switzerland (Brolucizumab)
Recruiting
- Age-related Macular Degeneration
- +5 more
- Brolucizumab
-
Regensburg, Bavaria, Germany
- +32 more
Jan 20, 2023
Age-Related Macular Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy Trial in New York (OCT Imaging Using
Not yet recruiting
- Age-Related Macular Degeneration
- +5 more
- OCT Imaging Using Device N
- OCT Imaging Using Device C
-
New York, New YorkNYU Langone Health
Jan 6, 2023
Artificial Intelligent System for Eye Emergency Triage and
Recruiting
- Emergencies
- Eye Diseases
- Artificial intelligent system for eye emergency triage and primary diagnosis
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen Univerisity
Dec 25, 2022
Presbyopia, Refractive Error, Near Vision Trial in Glendale (Aceclidine + Brimonidine, Aceclidine, Brimonidine)
Recruiting
- Presbyopia
- +4 more
- Aceclidine + Brimonidine
- +2 more
-
Glendale, CaliforniaSite #101
Jan 10, 2023
Eye Diseases Trial in Damieta (Transcutaneous levator recession)
Completed
- Eye Diseases
- Transcutaneous levator recession
-
Damieta, New Damietta, EgyptEhab tharwat
Jan 1, 2023
Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)
Not yet recruiting
- Myopia
- +3 more
- RLRL
-
Shanghai, Shanghai, ChinaShanghai Eye Disease Prevention and Treatment Center
Oct 24, 2022
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Completed
- Presbyopia
- +2 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +4 more
Oct 18, 2022
High Myopia, Refractive Errors, Eye Diseases Trial in Shanghai (RLRL)
Not yet recruiting
- High Myopia
- +2 more
- RLRL
-
Shanghai, Shanghai, ChinaShanghai Eye Disease Prevention and Treatment Center
Oct 17, 2022
Multimodal Equipment for Teleophthalmology Assessment (META)
Not yet recruiting
- Eye Diseases
- META
- Commercial devices
- (no location specified)
Oct 3, 2022
Prophylactic PRP in Moderate NPDR
Completed
- Eye Diseases
- +2 more
- PRP
-
Assiut, EgyptAssiut University
Sep 14, 2022
Eye Diseases Trial in Vienna (Laquinimod, Placebo)
Recruiting
- Eye Diseases
- Laquinimod
- Placebo
-
Vienna, AustriaClinical trial center at Medical University Vienna
Aug 9, 2022
Presbyopia, Refractive Errors, Eye Diseases Trial in United States (Aceclidine+Brimonidine combination ophthalmic solution,
Recruiting
- Presbyopia
- +4 more
- Aceclidine+Brimonidine combination ophthalmic solution
- +2 more
-
Glendale, California
- +3 more
Aug 3, 2022
Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2
Recruiting
- Eye Diseases
- +2 more
- Pars plana vitrectomy
- +3 more
-
Chelmsford, Essex, United Kingdom
- +13 more
Aug 2, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)
Recruiting
- Retinitis Pigmentosa
- +7 more
- Ultevursen
- Sham-procedure
-
San Diego, California
- +14 more
Jul 29, 2022
Ocular Microbiome in Health and Disease
Recruiting
- Microbial Colonization
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jul 25, 2022
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Trachomatous Trichiasis (TT), Eye Diseases, Eyelid Diseases Trial in Addis Ababa (Fluorometholone 0.1% Oph Susp, Artificial
Recruiting
- Trachomatous Trichiasis (TT)
- +4 more
- Fluorometholone 0.1% Oph Susp
- Artificial Tears
-
Addis Ababa, EthiopiaMinistry of Science and Higher Education Ethiopia
Jun 24, 2022
Macular Degeneration, Retinal Degeneration, Retinal Diseases Trial in Boston (Pistachio Group)
Recruiting
- Macular Degeneration
- +3 more
- Pistachio Group
-
Boston, MassachusettsClinical and Translational Research Center (CTRC) - Tufts
Jun 9, 2022
Natural History Study of CEP290-Related Retinal Degeneration
Completed
- Blindness
- +7 more
-
Miami, Florida
- +6 more
May 18, 2022
Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)
Completed
- Age-Related Maculopathy
- +4 more
- RN6G
- Placebo
-
Campbell, California
- +23 more
May 10, 2022
Eye Diseases Trial in Guangzhou
Recruiting
- Eye Diseases
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
May 4, 2022
Eye Diseases, Ametropia Trial in Paris (SiVIEW software, Expert)
Not yet recruiting
- Eye Diseases
- Ametropia
- SiVIEW software
- Expert
-
Paris, FranceOphthalmological Foundation A. de Rothschild
May 4, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)
Active, not recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
-
Dallas, Texas
- +2 more
Apr 21, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose
Completed
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
-
Boston, Massachusetts
- +6 more
Apr 19, 2022
Open Angle Glaucoma, Eye Diseases Trial in Guangzhou (RLRL therapy, Routine IOP-lowering medications)
Not yet recruiting
- Open Angle Glaucoma
- Eye Diseases
- RLRL therapy
- Routine IOP-lowering medications
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Mar 25, 2022